Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...
Panelists discuss how clinicians manage suboptimal responders by focusing on stability rather than complete dryness, using ...
A large international study 1 published in the British Journal of Ophthalmology has extended the knowledge about monkeypox ...
The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...
Thorne, MD, PhD, discusses evidence from the ADJUST trial, including relapse risk, retreatment success, and how clinicians ...
Faster thinning of cpRNFL and mGCIPL is associated with visual field progression in glaucoma, with rates of –1.02 and –1.04 ...
The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials ...
Joel S. Schuman, MD, FACS, highlights home tonometry, virtual visual fields, and portable OCT devices as promising tools, ...
Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...
The Light Adjustable Lens (LAL) enables rapid achievement of excellent visual acuity, often reaching 20/25 or 20/20 on the first postoperative day. Patient selection is crucial; detail-oriented ...
Michaelides is professor at UCL Institute of Ophthalmology and Moorfields Eye Hospital, London.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback